Search research articles
Contact Us
Filters
Showing results (501-510 of 510) with videos related to
Page
of 51
Sort By:
You have reached the last page of results.
This site can display upto 510 results.
Cancer Research
|
April 5, 2013
Cisplatin resistance associated with PARP hyperactivation
Judith Michels, Ilio Vitale, Lorenzo Galluzzi, et al.
BMJ Open
|
October 15, 2025
Systematic protocol to identify 'clinical controls' for paediatric neuroimaging research from clinically acquired brain MRIs
Dabriel Zimmerman, Ayan S Mandal, Benjamin Jung, et al.
JCI Insight
|
October 5, 2016
PRL3-zumab, a first-in-class humanized antibody for cancer therapy
Min Thura, Abdul Qader Omer Al-Aidaroos, Wei Peng Yong, et al.
Immunity
|
April 9, 2013
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells
Yuting Ma, Sandy Adjemian, Stephen R Mattarollo, et al.
Cell Death & Disease
|
December 20, 2025
Targeting secreted PLA<sub>2</sub> interactions with EGFR and vimentin to arrest prostate tumour growth
Timothy J Mann, Ryung Rae Kim, Mila Sajinovic, et al.
Regulatory Toxicology and Pharmacology : RTP
|
May 17, 2020
Hydroalcoholic extract of leaf of Arachis hypogaea L. (Fabaceae) did not induce toxic effects in the repeated-dose toxicity study in rats
Jocelene Filippin Cossetin, Amanda Spring de Almeida, Caren Tatiane de David Antoniazzi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
January 28, 2021
Cardiac, Hepatic and Renal Dysfunction and IL-18 Polymorphism in Breast, Colorectal, and Prostate Cancer Patients
Govand Qader, Mukhlis Aali, Shukur W Smail, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
February 28, 2022
Cancer Incidence in the Kurdistan Region of Iraq: Results of a Seven-Year Cancer Registration in Erbil and Duhok Governorates
Karwan M-Amen, Omiad S Abdullah, Ahmed M S Amin, et al.
Nature Communications
|
June 8, 2019
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
Min Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta, et al.
Oncoimmunology
|
May 6, 2015
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp, Laura Senovilla, Ilio Vitale, et al.
Page
of 51
Search research articles
Search
Showing results (501-510 of 510) with videos related to
Sort By:
Page
of 51
You have reached the last page of results.
This site can display upto 510 results.
Cancer Research
|
April 5, 2013
Cisplatin resistance associated with PARP hyperactivation
Judith Michels, Ilio Vitale, Lorenzo Galluzzi, et al.
BMJ Open
|
October 15, 2025
Systematic protocol to identify 'clinical controls' for paediatric neuroimaging research from clinically acquired brain MRIs
Dabriel Zimmerman, Ayan S Mandal, Benjamin Jung, et al.
JCI Insight
|
October 5, 2016
PRL3-zumab, a first-in-class humanized antibody for cancer therapy
Min Thura, Abdul Qader Omer Al-Aidaroos, Wei Peng Yong, et al.
Immunity
|
April 9, 2013
Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells
Yuting Ma, Sandy Adjemian, Stephen R Mattarollo, et al.
Cell Death & Disease
|
December 20, 2025
Targeting secreted PLA<sub>2</sub> interactions with EGFR and vimentin to arrest prostate tumour growth
Timothy J Mann, Ryung Rae Kim, Mila Sajinovic, et al.
Regulatory Toxicology and Pharmacology : RTP
|
May 17, 2020
Hydroalcoholic extract of leaf of Arachis hypogaea L. (Fabaceae) did not induce toxic effects in the repeated-dose toxicity study in rats
Jocelene Filippin Cossetin, Amanda Spring de Almeida, Caren Tatiane de David Antoniazzi, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
January 28, 2021
Cardiac, Hepatic and Renal Dysfunction and IL-18 Polymorphism in Breast, Colorectal, and Prostate Cancer Patients
Govand Qader, Mukhlis Aali, Shukur W Smail, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
February 28, 2022
Cancer Incidence in the Kurdistan Region of Iraq: Results of a Seven-Year Cancer Registration in Erbil and Duhok Governorates
Karwan M-Amen, Omiad S Abdullah, Ahmed M S Amin, et al.
Nature Communications
|
June 8, 2019
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
Min Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta, et al.
Oncoimmunology
|
May 6, 2015
Consensus guidelines for the detection of immunogenic cell death
Oliver Kepp, Laura Senovilla, Ilio Vitale, et al.
Page
of 51